semaglutide sglt2 inhibitor Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation GLP1 Receptor Agonists vs SGLT2-I

Semaglutide may be especially familiar to patients because of its established role in obesity and diabetes care

For chronic weight management, the higher-dose injectable formulation (Wegovy) is approved for adults with a body mass index (BMI) of 30 kg/m or greater (obesity), or a BMI of 27 kg/m or greater (overweight) in the presence of at least one weight-related comorbid condition

He was referred to our department with a suspected diagnosis of NAION

I come monthly for facials and always given the best possible treatment: in depth consults, insight into the procedure and advice for aftercare

GLP-1 stands for glucagon-like peptide-1, a natural hormone in our body that is crucial in controlling blood sugar levels and digestion

Bottom line: The combined effect of these medications can lead to significant nutrient deficiencies that may outweigh the benefits of faster weight loss